5-Dec-2024 5:30 AM CST - Business Wire KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today released financial results for the second fiscal quarter ended October 31, 2024. The Company also provided an operational update, highlighted by the U.S. Food and Drug Administration (FDA) acceptance of a New Drug Application (NDA) for sebetralstat, a novel, investigational treatment for hereditary angioedema (HAE). KalVista is successfully executing on the key milestones we announced a
12-Nov-2024 5:30 AM CST - Business Wire KalVista Pharmaceuticals to Present at Upcoming Investor Conferences KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the Company will participate in a fireside chat at each of the following investor conferences: Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024, at 9:10 a.m. EST Jefferies London Healthcare Conference on Thursday, November 21, 2024, at 11:00 a.m. GMT Each presentation will be live webcast on the Companys website at www.kalvista.com. After the presentations,
5-Dec-2024 5:30 AM CST - Business Wire KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today released financial results for the second fiscal quarter ended October 31, 2024. The Company also provided an operational update, highlighted by the U.S. Food and Drug Administration (FDA) acceptance of a New Drug Application (NDA) for sebetralstat, a novel, investigational treatment for hereditary angioedema (HAE). KalVista is successfully executing on the key milestones we announced a
12-Nov-2024 5:30 AM CST - Business Wire KalVista Pharmaceuticals to Present at Upcoming Investor Conferences KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the Company will participate in a fireside chat at each of the following investor conferences: Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024, at 9:10 a.m. EST Jefferies London Healthcare Conference on Thursday, November 21, 2024, at 11:00 a.m. GMT Each presentation will be live webcast on the Companys website at www.kalvista.com. After the presentations,
